TICKERNERD
Menu
ALGNALGNHealthcare · Medical Instruments & Supplies

ALGN Stock Forecast: Align Technology, Inc. Price Predictions for 2026-2027

Last close, 5 Oct 2026
$141
−2.15% on the day

The 16 Wall Street analysts covering Align Technology, Inc. hold a median 12-month price target of $207 — +47.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 3 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$10.2B
Ticker Nerd rank
84 / 100
Median analyst target
$207
Analysts covering
16
Revenue$1.1B+4.3% y/y
Operating income$192.7M
Net income$108.3M
Free cash flow$157.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.0%
1M
−11.3%
YTD
−9.9%
1Y
+6.4%
From 52W high
−28.8%
From 52W low
+11.8%
$126
$198
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ALGN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Align Technology, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026
84 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
97
Issuance
84
Quality
82
Accruals
73
Growth
67
Volatility
64
Revisions
55
Momentum
52
Size
15

Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (52): The shares have been drifting down relative to others.

Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ALGN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALGN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$120$140$160$180$200$220$240Jan 26Apr 26Jul 26Oct 26ALGNHigh $235Median $207Low $170

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says16 analysts
10 Buy5 Hold1 Sell
Low $170Median $207High $235

The green dot is the last close — the median target sits +47.2% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
23 July 2026UBSMaintainsNeutral$186 → $189
9 July 2026BMO CapitalInitiatesOutperform$209
9 July 2026BMO CapitalInitiatesOutperform—
30 Apr 2026Evercore ISI GroupMaintainsOutperform—
30 Apr 2026MizuhoMaintainsOutperform—
24 Apr 2026Morgan StanleyMaintainsEqual-Weight—
21 Apr 2026Piper SandlerMaintainsOverweight—
15 Apr 2026CitigroupInitiatesBuy—
17 Mar 2026BarclaysUpgradeOverweight—
26 Feb 2026BarclaysMaintainsEqual-Weight—
9 Feb 2026HSBCUpgradeBuy—
5 Feb 2026Evercore ISI GroupMaintainsOutperform—
5 Feb 2026Morgan StanleyMaintainsEqual-Weight—
5 Feb 2026Piper SandlerMaintainsOverweight—
5 Feb 2026StifelMaintainsBuy—
5 Feb 2026UBSMaintainsNeutral—
5 Feb 2026Wells FargoMaintainsOverweight—
20 Jan 2026MizuhoMaintainsOutperform—
9 Dec 2025BarclaysInitiatesEqual-Weight—
30 Oct 2025Evercore ISI GroupMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALGN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ALGN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 5 Oct 2026, Align Technology, Inc. returned +6.4% against +16.2% for the S&P 500, dividends included.

ALGN vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140150Jan 26Apr 26Jul 26Oct 26ALGNS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ALGN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−0.6%
Analysts raising
3
Analysts cutting
10
Fundamentals

Align Technology, Inc. (ALGN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.0×

Cheaper than 30% of US stocks

Price / sales
2.5×

Cheaper than 46% of US stocks

Price / book
2.4×

Cheaper than 38% of US stocks

EV / EBITDA
10.0×

Cheaper than 38% of US stocks

Growth & margins
Revenue growth (YoY)
4.3%

Higher than 37% of US stocks

Earnings growth (YoY)
−13.1%

Higher than 24% of US stocks

Gross margin
71.7%

Higher than 84% of US stocks

Operating margin
18.2%

Higher than 77% of US stocks

Net margin
10.0%

Higher than 70% of US stocks

Returns & dividend
Return on equity
10.2%

Higher than 64% of US stocks

Return on assets
7.6%

Higher than 87% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Align Technology, Inc. (ALGN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Align Technology, Inc. has a market value of $10.2B and an enterprise value of $9.2B.

  • Revenue in the twelve months to 30 June 2026: $4.1B. The latest quarter grew 4.3% year on year.

  • Net income over the same four quarters: $413.6M, a 10.0% net margin.

  • Diluted earnings per share, trailing twelve months: $5.75.

  • Free cash flow in the twelve months to 30 June 2026: $633.6M.

  • Align Technology, Inc. spent $266.9M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 71.2M.

  • Trailing P/E: 25.0×; forward P/E: 11.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Align Technology, Inc. employs 20,435 people — $203K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 4 Oct 2026

Data provided by Twelve Data

Peers

ALGN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ALGNAlign Technology, Inc.$10.2B
84
RGENRepligen Corp.$10.2B
92
AVTRAvantor, Inc.$10.5B
82
COOThe Cooper Cos., Inc.$11.2B
71
BAXBaxter International, Inc.$12.1B
90
ATRAptarGroup, Inc.$7.9B
51
SOLVSolventum Corp.$15.2B
92

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Align Technology, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ALGN news & analysis

Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?

Zacks Investment Research · 2 Oct 2026positive

Zacks Investment Research reports that Align Technology (ALGN) has a strong earnings surprise history and currently holds the combination of two key factors that suggest a likely earnings beat in its next quarterly report.

Why it matters — ALGN watchers would care because the company's track record and current positioning point to a potential favorable outcome in the upcoming earnings report.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research · 2 Oct 2026neutral

Zacks Investment Research highlights two medical stocks that could potentially beat earnings, using the Zacks Earnings ESP as a tool to identify potential earnings surprises. The article suggests investors should take advantage of this approach now.

Why it matters — An Align Technology watcher would care because the article's methodology for flagging potential earnings surprises may be relevant to evaluating earnings-related signals for the stock.

Align Technology to Announce Third Quarter 2026 Results on October 28, 2026

Business Wire · 1 Oct 2026neutral

Align Technology announced it will report its third quarter 2026 financial results on Wednesday, October 28, 2026, after the market closes, with results to be released at 4:00 p.m. ET (1:00 p.m. PT).

Why it matters — The announcement gives Align Technology investors and analysts a confirmed date and time for the upcoming quarterly financial report, which is a key scheduled event for monitoring the company's performance.

Align Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement

Business Wire · 28 Sept 2026positive

Align Technology announced the launch of "SHIFT Happens," a new U.S. consumer campaign designed to help Invisalign-trained doctors connect with and educate adult consumers about lifelong tooth movement. The campaign was announced via Business Wire.

Why it matters — ALGN watchers would care because the campaign is aimed at driving consumer education and engagement, potentially supporting demand for the company's Invisalign clear aligner system.

Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds

MarketBeat · 18 Sept 2026positive

At a Baird investor conference, Align Technology's CFO John Morici said the company sees continued growth potential for Invisalign clear aligners in the United States and internationally, despite a challenging consumer environment.

Why it matters — ALGN watchers would care because the CFO's outlook speaks directly to the company's core Invisalign growth trajectory amid broader consumer spending headwinds.

FAQ

Frequently asked questions about ALGN stock

What is the ALGN stock price forecast for 2026-2027?

The 16 Wall Street analysts covering Align Technology, Inc. have a median 12-month price target of $207, with estimates ranging from $170 to $235. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ALGN stock a buy right now?

Of the 16 analysts covering Align Technology, Inc., 10 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Align Technology, Inc. 84 out of 100 across roughly 4,600 US stocks as at 3 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ALGN?

As at 3 Oct 2026, Align Technology, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).

Will ALGN stock go up?

No one can know that. What the data says: the median 12-month target from 16 analysts implies +47.2% from the last close, and Ticker Nerd's factor model ranks Align Technology, Inc. 84 out of 100 as at 3 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ALGN stock forecast for 2030?

No analyst covering Align Technology, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALGN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $170 to $235 over the next 12 months.

How has ALGN stock performed over the past year?

Align Technology, Inc. returned +6.4% over the 12 months to 5 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Align Technology, Inc. do?

Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry.

What is the latest news on ALGN?

The most recent item we track (Zacks Investment Research, 2 Oct 2026): "Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?". Zacks Investment Research reports that Align Technology (ALGN) has a strong earnings surprise history and currently holds the combination of two key factors that suggest a likely earnings beat in its next quarterly report.

Company

About Align Technology, Inc.

Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.

CEO Mr. Joseph M. Hogan · 20,435 employees · United States · https://www.aligntech.com